Tonix Pharmaceuticals (TNXP) Q4 2024 Earnings

12NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-388
-259.16
-130.33
-1.49

Details

Expected EPS
-388
Actual EPS
-23
Surprise EPS
365
Surprise Percent
+94.07%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -23 per share for Q4 2024.

0 Comments

Share your thoughts